13F filer · CIK 1562230 ↗
Capital International Investors
You are looking at Q4 2018. See the latest, Q2 2026 →
Reported value
$200.60B
−8.1% on the quarter before
Positions
377
28 new · 30 sold out
Top 10
26.8%
of the value
Est. gain
−$25.39B
on stocks held all quarter
Est. return
−12.4%
on those stocks since Q3 2018
Positions as of Dec 31, 2018, from Capital International Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 45% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2018. Striped tiles are options.
Largest buys
Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Northrop Grumman Corp~$1.35BAdded · 0.7% → 1.2%+5,522,390 shares
- Cigna Corp~$984.7MNew · 0.0% → 0.5%+5,184,723 shares
- Linde Plc~$800.6MNew · 0.0% → 0.4%+5,130,808 shares
- Intercontinental Exchange Inc~$755.5MAdded · 0.4% → 0.8%+10,028,824 shares
- Meta~$717.0MAdded · 2.3% → 2.4%+5,469,577 shares
- Eog Resources Inc~$695.0MAdded · 1.2% → 1.2%+7,969,819 shares
- Cvs Health Corp~$617.5MAdded · 0.3% → 0.6%+9,424,667 shares
- Edison International~$609.8MAdded · 0.3% → 0.6%+10,741,548 shares
- Broadcom~$519.0MAdded · 3.1% → 3.7%+2,041,035 shares
- Bank Of New York Mellon Corp~$484.1MAdded · 0.5% → 0.7%+10,285,485 shares
Largest sells
Since Q3 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Aetna Inc~$2.55BSold out · 1.2% → 0.0%−12,568,723 shares
- Express Scripts Holding Co~$1.13BSold out · 0.5% → 0.0%−11,842,955 shares
- American International Group Inc~$444.8MCut · 0.3% → 0.0%−11,286,987 shares
- Accenture Plc Cl A~$425.1MCut · 0.4% → 0.1%−3,014,443 shares
- Cimarex Energy Co~$418.2MSold out · 0.2% → 0.0%−4,500,000 shares
- Lockheed Martin Corp~$401.0MCut · 0.5% → 0.3%−1,531,434 shares
- General Dynamics Corp~$361.4MCut · 0.2% → 0.0%−2,299,061 shares
- Commscope Holding Co Inc~$288.4MSold out · 0.1% → 0.0%−9,377,000 shares
- Xilinx Inc~$285.5MCut · 0.3% → 0.2%−3,352,483 shares
- Jpmorgan Chase And Co~$274.6MCut · 1.4% → 1.2%−2,813,448 shares
Holdings
As of Dec 31, 2018. Changes are in shares against Sep 30, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOMMON STOCK · shares +1.0% · price −11.2% | 4.7% | $9.42B | −$1.17B | ||||||||
| BroadcomCOMMON STOCK · shares +7.4% · price +3.1% | 3.7% | $7.51B | +$207.7M | ||||||||
| AmazonCOMMON STOCK · shares +2.1% · price −25.0% | 3.5% | $6.97B | −$2.28B | ||||||||
| IntelCOMMON STOCK · shares +2.2% · price −0.8% | 2.6% | $5.18B | −$38.9M | ||||||||
| MetaCOMMON STOCK · shares +18% · price −20.3% | 2.4% | $4.72B | −$1.02B | ||||||||
| Unitedhealth Group IncCOMMON STOCK · shares +4.2% · price −6.4% | 2.1% | $4.23B | −$276.1M | ||||||||
| Wells Fargo And CoCOMMON STOCK · shares +1.1% · price −12.3% | 2.1% | $4.18B | −$581.7M | ||||||||
| Comcast Corp Cl ACOMMON STOCK · shares −1.8% · price −3.8% | 2.0% | $4.10B | −$163.8M | ||||||||
| AlphabetCOMMON STOCK · shares +0.5% · price −13.2% | 2.0% | $4.04B | −$613.3M | ||||||||
| Enbridge IncCOMMON STOCK · shares +5.8% · price −3.7% | 1.7% | $3.32B | −$121.9M | ||||||||
| Johnson And JohnsonCOMMON STOCK · shares +0.2% · price −6.6% | 1.6% | $3.23B | −$227.9M | ||||||||
| Coca-Cola CoCOMMON STOCK · shares +0.6% · price +2.5% | 1.5% | $3.01B | +$73.3M | ||||||||
| Chevron CorpCOMMON STOCK · shares +15% · price −11.0% | 1.5% | $2.98B | −$320.5M | ||||||||
| Cme Group Inc Cl ACOMMON STOCK · shares −3.5% · price +10.5% | 1.4% | $2.80B | +$266.6M | ||||||||
| Abbvie IncCOMMON STOCK · shares +7.3% · price −2.5% | 1.4% | $2.73B | −$66.0M | ||||||||
| Merck And Co IncCOMMON STOCK · shares +0.7% · price +7.7% | 1.3% | $2.54B | +$180.4M | ||||||||
| Philip Morris InternationalCOMMON STOCK · shares +9.2% · price −18.1% | 1.2% | $2.47B | −$501.0M | ||||||||
| Eog Resources IncCOMMON STOCK · shares +39% · price −31.6% | 1.2% | $2.47B | −$819.6M | ||||||||
| Northrop Grumman CorpCOMMON STOCK · shares +122% · price −22.8% | 1.2% | $2.46B | −$328.0M | ||||||||
| Jpmorgan Chase And CoCOMMON STOCK · shares −11% · price −13.5% | 1.2% | $2.32B | −$361.7M | ||||||||
| Humana IncCOMMON STOCK · shares −1.6% · price −15.4% | 1.2% | $2.32B | −$420.8M | ||||||||
| Chubb LtdCOMMON STOCK · shares +0.03% · price −3.3% | 1.1% | $2.30B | −$79.5M | ||||||||
| Verizon Communications IncCOMMON STOCK · shares −6.8% · price +5.3% | 1.1% | $2.25B | +$113.5M | ||||||||
| Amgen IncCOMMON STOCK · shares −4.4% · price −6.1% | 1.0% | $2.06B | −$133.9M | ||||||||
| Visa Inc.COMMON STOCK · shares +17% · price −12.1% | 1.0% | $2.03B | −$238.7M | ||||||||
| Total · 377 positions | 100% | $200.60B | −$25.39B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2018 to Q4 2018: 343 stocks held throughout, down $25.39B (−12.4%).
- Cme Group Inc Cl A+$266.6M+11%
- Neurocrine Biosciences Inc14:1 split+$220.8M+713%
- Broadcom+$207.7M+3%
- Merck And Co Inc+$180.4M+8%
- Verizon Communications Inc+$113.5M+5%
- Eog Resources Inc−$819.6M−32%
- Schlumberger Ltd−$827.1M−41%
- Meta−$1.02B−20%
- Microsoft−$1.17B−11%
- Amazon−$2.28B−25%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $483.61B+13% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $426.52B−33% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $637.97B+3% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $619.40B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $580.56B+14% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $508.52B−4% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $532.30B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $520.97B+7% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $485.73B−2% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $493.90B+11% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $446.09B+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $394.11B−5% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $414.45B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $388.71B+4% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $372.54B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $342.83B−7% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $367.64B−16% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $438.61B−7% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $473.03B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $437.44B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $437.89B+11% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $395.24B+8% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $366.38B+13% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $323.46B+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $305.21B+25% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $244.50B−17% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $294.42B+12% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $261.94B+5% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $250.64B+8% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $232.80B+16% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $200.60B−8% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $218.36B+147% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $88.55B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $86.51B−2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $88.52B+6% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $83.48B+11% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $74.88B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $73.61B+6% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $69.28B+0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $68.95B+1% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $68.21B+5% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $65.22B | SEC ↗ |